These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23107940)

  • 1. In vitro and in vivo evaluation of riccardin D nanosuspensions with different particle size.
    Liu G; Zhang D; Jiao Y; Guo H; Zheng D; Jia L; Duan C; Liu Y; Tian X; Shen J; Li C; Zhang Q; Lou H
    Colloids Surf B Biointerfaces; 2013 Feb; 102():620-6. PubMed ID: 23107940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
    Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
    Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absorption, distribution, metabolism and excretion of Riccardin D in rats.
    Ling X; Xing J; Zhang JZ; Chen WF; Zan X; Du FY; Li XX; Yao H; Lou HX
    Drug Res (Stuttg); 2013 Mar; 63(3):159-64. PubMed ID: 23430703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
    Liu G; Zhang D; Jiao Y; Zheng D; Liu Y; Duan C; Jia L; Zhang Q; Lou H
    Int J Pharm; 2012 Jan; 422(1-2):516-22. PubMed ID: 22119965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
    Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
    Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
    Guo JJ; Yue PF; Lv JL; Han J; Fu SS; Jin SX; Jin SY; Yuan HL
    Int J Pharm; 2013 Jan; 441(1-2):227-33. PubMed ID: 23220096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
    Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
    Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.
    Sigfridsson K; Lundqvist AJ; Strimfors M
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1479-86. PubMed ID: 19929207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.
    Sun CC; Zhang YS; Xue X; Cheng YN; Liu HP; Zhao CR; Lou HX; Qu XJ
    Eur J Pharmacol; 2011 Sep; 667(1-3):136-43. PubMed ID: 21704029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.
    Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y
    Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
    Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
    PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro-in vivo characterization of trans-resveratrol nanosuspensions.
    Dong Q; Yuan HL; Qian JJ; Zhang CY; Chen WD
    Biomed Mater Eng; 2018; 29(3):333-345. PubMed ID: 29578462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery.
    Liu Y; Zhang D; Duan C; Jia L; Xie P; Zheng D; Wang F; Liu G; Hao L; Zhang X; Zhang Q
    J Microencapsul; 2012; 29(2):194-203. PubMed ID: 22172025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
    Tian X; Li H; Zhang D; Liu G; Jia L; Zheng D; Shen J; Shen Y; Zhang Q
    Colloids Surf B Biointerfaces; 2013 Aug; 108():29-33. PubMed ID: 23528604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.
    He W; Lu Y; Qi J; Chen L; Hu F; Wu W
    Int J Pharm; 2013 Jan; 441(1-2):269-78. PubMed ID: 23194889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pluronic nanosuspensions loading a novel insoluble anticancer drug both in vitro and in vivo.
    Tang XJ; Fu YH; Meng QH; Li LM; Ying XY; Han M; He QJ; Yang B; Zeng S; Hu YZ; Sheng XX; Gao JQ
    Int J Pharm; 2013 Nov; 456(1):243-50. PubMed ID: 23928148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do in-vitro release profiles of nanosuspensions from Alzet® pumps correspond to the in-vivo situation? A case study on radiolabeled fenofibrate.
    Hill A; Breyer S; Geissler S; Mier W; Haberkorn U; Weigandt M; Mäder K
    J Control Release; 2013 May; 168(1):77-87. PubMed ID: 23499716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle size tailoring of ursolic acid nanosuspensions for improved anticancer activity by controlled antisolvent precipitation.
    Wang Y; Song J; Chow SF; Chow AH; Zheng Y
    Int J Pharm; 2015 Oct; 494(1):479-89. PubMed ID: 26302857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
    Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the NF‑κB signaling pathway in colon cancer cells by the natural compound Riccardin D from Dumortierahirsute.
    Liu H; Li G; Zhang B; Sun D; Wu J; Chen F; Kong F; Luan Y; Jiang W; Wang R; Xue X
    Mol Med Rep; 2018 Apr; 17(4):5837-5843. PubMed ID: 29484409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.